PW
CBMG

Prem Watsa’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Prem Watsa’s Portfolio CBMG Stock Details CBMG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,600
Closed -$158K – 66
2020
Q4 		$158K Buy
+8,600
New +$157K 0.01% 59

Prem Watsa's CBMG Position: Q1 2021 in Review

Prem Watsa sold out of Cellular Biomedicine Group, Inc. (CBMG) in Q1 2021, closing a stake of 8,600 shares — an estimated $158K sold.

Prem Watsa first reported a position in CBMG in Q4 2020 and held it in 1 quarter. The position peaked at $158K in Q4 2020. 0 funds tracked by Wall St. Rank hold CBMG as of Q1 2021.

  • Prem Watsa reported no remaining Cellular Biomedicine Group, Inc. position as of Q1 2021 after selling out during the quarter.
  • Prem Watsa sold 8,600 Cellular Biomedicine Group, Inc. shares in Q1 2021, an estimated $158K.
  • Prem Watsa first reported a position in Cellular Biomedicine Group, Inc. in Q4 2020 and held it in 1 quarter.
  • Prem Watsa's Cellular Biomedicine Group, Inc. position peaked at $158K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Cellular Biomedicine Group, Inc. as of Q1 2021.

Based on Fairfax Financial Holdings's 13F filing for Q1 2021, filed 14 May 2021.